EU ‘Structured Dialog’ Offers Opportunity To Secure Supply

Industry Calls For Policies, Investment And Regulation To Support Manufacturing

A “structured dialog” led by the European Commission with pharmaceutical industry stakeholders provides a critical opportunity to address weaknesses in the stability and security of the supply chain by improving the environment for local manufacturing, Medicines for Europe believes.

Made In EU Stamp
Bolstering manufacturing capacity is part of the EU pharma strategy • Source: Shutterstock

A “structured dialog” with pharmaceutical industry stakeholders that has been initiated by the European Commission offers an opportunity to bolster the environment for local manufacturing and address weaknesses in the stability and security of the supply chain, according to local off-patent industry association Medicines for Europe.

The move represents an initial step to implement the EU Pharma Strategy that was set out in November last year....

Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

More from Manufacturing

More from Business